Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Investor Presentation
July 2019
2
Forward-Looking Statements
This Presentation has been prepared by Calumet Specialty Products Partners, L.P. (the “Company” or “Calumet”) as of July 23, 2019. The information in this
Presentation includes certain “forward-looking statements.” These statements can be identified by the use of forward-looking terminology including “may,” “intend,”
“believe,” “expect,” “anticipate,” “estimate,” “forecast,” “continue” or other similar words. The statements discussed in this Presentation that are not purely historical
data are forward-looking statements. These forward-looking statements discuss future expectations or state other “forward-looking” information and involved risks and
uncertainties. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in our most recent
Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The risk factors and other factors noted in our most recent Annual Report on Form 10-K and
Quarterly Report on Form 10-Q could cause our actual results to differ materially from those contained in any forward-looking statement.
Our forward-looking statements are not guarantees of future performance, and actual results and future performance may differ materially from those suggested in
any forward-looking statement. All subsequent written and oral forward-looking statements attributable to us or to persons acting on our behalf are expressly qualified
in their entirety by the foregoing. Existing and prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only
as of the date of this Presentation. We undertake no obligation to publicly release the results of any revisions to any such forward-looking statements that may be
made to reflect events or circumstances after the date of this Presentation or to reflect the occurrence of unanticipated events.
The information contained herein has been prepared to assist interested parties in making their own evaluation of the Company and does not purport to contain all of
the information that an interested party may desire. In all cases, interested parties should conduct their own investigation and analysis of the Company, its assets,
financial condition and prospects and of the data set forth in this Presentation. This Presentation shall not be deemed an indication of the state of affairs of the
Company, or its businesses described herein, at any time after the date of this Presentation nor an indication that there has been no change in such matters since the
date of this Presentation.
This Presentation and any other information which you may be given at the time of presentation, in whatever form, do not constitute or form part of any offer or
invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any securities of the Company, nor shall it or any part of it form the basis of, or be
relied upon in connection with, any contract or commitment whatsoever. Neither this Presentation nor any information included herein should be construed as or
constitute a part of a recommendation regarding the securities of the Company. Furthermore, no representation or warranty (express or implied) is made as to, and no
reliance should be placed on, any information, including projections, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to
any errors, omissions or misstatements contained herein. Neither the Company nor any of its officers or employees accepts any liability whatsoever arising directly or
indirectly from the use of this Presentation.
Today’s Presenters
Timothy Go – Chief Executive Officer
Started with the company in September 2015
VP of Operations, Flint Hills Resources, LP, 7+ years
Exxon Mobil Corporation, 18+ years
D. West Griffin – Executive Vice President & Chief
Financial Officer
Started with the company in January 2017
CFO, Energy XXI, 9 years
CFO, Alon USA, 1 year
Sandy Smith – Director, FP&A and Investor Relations
Started with the company in February 2017
Responsible for the corporate model, forecasting,
and asset profitability analysis
7+ years of Financial Modeling and Corporate
Finance experience
3
Jean-Pierre Breaux – Treasurer
Started with the company in November 2018
Responsible for strategic Treasury direction and
management of capital structure
8+ years of Treasury Management experience
Doyle Schrock – Assistant Treasurer
Started with the company in March 2013
Responsible for Treasury operations, cash and
liquidity management, inventory finance
arrangements and debt compliance
12+ years of Treasury Management experience
4
Agenda
1. Calumet Overview
A. Specialty Products
B. Fuel Products
2. Calumet’s Evolution
3. Financial Update
4. Appendix
Calumet Overview
5
6
Calumet at a Glance
Production and Manufacturing Footprint
(1) LTM ended March 31, 2019
(2) Based on 77.5 million LP units outstanding and unit price of $4.69 as of 7/19/2019.
(3) Defined as Pro Forma EBITDA excluding LCM/LIFO. See Appendix to this presentation for GAAP to Non GAAP, including LCM/LIFO adjustments.
Leading independent producer
of high-quality, specialty
hydrocarbon products
Core Specialty Products
EBITDA of ~$200 million,
representing ~2/3rds of total
EBITDA
Fuel Products refineries
benefit from cost-advantaged
crude feedstocks
~3,400 unique specialty
products available in ~50
countries
Segments LTM EBITDA(1,3)
$287mm
Market Capitalization(2) Enterprise Value(2)
~$360mm ~$1.8bn
Business Highlights
Calumet is first and foremost a Specialty lubricants and chemicals company
LTM Sales(1)
$3.5bn Specialty Products
Fuel Products
Production focused markets
serving customers who value
superior quality and service
7
Calumet Supports Things You Use Every Day
Manufacturer of key components and solutions for numerous branded products that consumers use every day
Highly customized formulations
Stringent certifications, approvals and qualification requirements
Very strong and sticky/loyal customer base
Proud to partner with the world’s best companies to help deliver some of the world’s most trusted products
NOTE: The above customer trademarks are the property of their respective owners.
8
Calumet Portfolio: Focus on Specialty Products
LTM EBITDA by Segment(1,2) LTM Specialty Sales by Product
Quality-
Driven
~40%
Price-
Driven
~40%
Brand-
Driven
~20%
“PRICE-DRIVEN” “QUALITY-DRIVEN” “BRAND-DRIVEN”
Solvents Base Oils Specialty Oils and Waxes Finished Lubricants & Chemicals
Specialty Solvents
Paraffinic Base Oils
Naphthenic Base Oils
White Oils
Petrolatums
Esters
Waxes
Finished Lubricants & Chemicals (Royal Purple,
Bel-Ray, TruFuel)
Cosmetic and Pharma white oils (Penreco)
Higher MarginLower MarginPrioritizing Higher Margin Products
Lower VolumeHigher Volume
Specialty Products
~63%Fuel
Products~37%
(1) LTM ended March 31, 2019
(2) Defined as Pro Forma EBITDA excluding LCM/LIFO. See Appendix to this presentation for GAAP to Non GAAP, including LCM/LIFO adjustments.
9
Specialty Products Value Chain
OIL
Calumet is one of the few producers that is fully integrated and realizes the full uplift from crude oil
VGOs(Vacuum Gas Oils)
Diesel
Gasoline
Asphalt
Base Oils
Solvents
Specialty Asphalt
Fuel Products Specialty Products
Finished Lubricants
& Chemicals
White Oils,
Petrolatums, Gels
Margins
10
Calumet Investment Summary
Specialty
Products
Focus
Strong Execution
Against
Turnaround
Strategy
“Self-Help”
Driving EBITDA
Improvement
Innovation to
Drive Future
Performance
Strong Earnings
Stability
1 2 3 4 5
Meaningful leverage
reduction and balance
sheet improvement
Resulted in one-notch
ratings upgrade at
Moody’s and S&P
Realigned
organizational
structure and rebuilt
culture around P&L
ownership /
accountability and
cash flow
Refocused company
around highly-valued
Specialty lubricants
and chemical assets
High margin, high
touch, tailored
products for long-term
customers
Leading position in
niche specialty
products drives
customer stickiness
and long-term
defensibility in
performance
Self-Help Phase II
goal of adding
$100MM in new
EBITDA by YE’21
Delivered $13.5MM in
1Q19; expecting to
capture $25-$40MM in
FY’19
Successful Self-Help
Phase I (‘16-18’)
added ~$182MM in
EBITDA
Utilizing Specialty
pedigree and
proprietary tech to
drive bespoke
customer solutions
Implemented ERP
system to enable data-
driven business
optimization
Launched state-of-the-
art Innovation Center
in Indianapolis
Expanded capacity to
grow high margin
Finished Lubricants &
Chemicals business
In process of
rationalizing low
margin SKUs across
Specialty Products
Margin improvement
from shift to higher
margin products and
raw material
optimization
Specialty Products
11
12
Strong Specialty Products Portfolio
Specialty Products Business Units (~2/3rds of Total EBITDA)
DescriptionFinished Lubricants
& ChemicalsSpecialty Oils & Waxes Solvents Base Oils
Selected
Markets /
Products
Royal Purple
High performance motor oil
Industrial lubricants
Compression and refrigeration oils
Bel-Ray
Mining and food grade lubricants
and greases
Powersports lubricants and related
products
TruFuel
Pre-mixed engineered fuel
Candles
Adhesives
Crayons
Ointments for pharmaceuticals
Sunscreen
Cosmetics
Food grade lubricating oils
Food grade process oils
Esters for synthetic aircraft turbine
oils
Esters for lubrication oil for
refrigeration
Vaseline
Body washes
Paint and coatings and stains
Clean drilling fluids
Water treatment chemicals
Waterless hand cleaners
Printer inks and alkyd resin diluents
Automotive aftermarket
Mining extraction solvents
Aluminum rolling oils
Hydraulic oils
Railroad engine oils
Cutting oils
Engine oils
Refrigeration oils
Transformer oils
Rubber process oils
Open gear lubricants
Two-cycle engine oils
Viscosity improvers
Defoamer oils
Consumer
Relationships
and
End Markets
Paintings and Coatings
Aluminum
Water Treatment
Oil and Gas
Hydraulic Oils
Cutting Oils
Motor Oils
Conversion to Greases
White Oils Upgrade
Automotive
Landscape
EquipmentMining
2018 volumes and margins
pressured by ERP
implantation and peak in the
multi-year turnaround cycle
0%
5%
10%
15%
20%
25%
1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19
Quarterly Margin % LTM Margin %
13
Specialty Products Segment Provides Stable EBITDA Margins
Typical margins of ~13-15% on a LTM basis, showing significant stability across the context of the full-year
After performance was impacted by ERP implementation and turnaround activity in 2017 and 2018, Specialty products margins are on
the uptrend, driven by run-rate benefits from self-help program and volume growth in higher-margin products
Quarterly Margin % LTM Margin %
Adjusted EBITDA (excl. LCM/LIFO)(1)
(1) See Appendix to this presentation for GAAP to Non GAAP, including LCM/LIFO adjustments.
14
Specialty Products EBITDA Driven by Predictable Factors
Core Specialty Products EBITDA of ~$200
million and growing, but variability on a
quarterly basis is impacted by two key
factors:
– % change in Light Louisiana Sweet (LLS)
– Inversely related to Adj. EBITDA
(excl. LCM/LIFO)(1)
– Pricing adjustments typically
have 8-12 week lag time
– Seasonality
– Q1 and Q2 generally the
strongest quarters in the year
– Q4 performance consistently
weaker
Adj. EBITDA (excl. LCM/LIFO)(1) Affected by Changes in LLS
Adj. EBITDA (excl. LCM/LIFO)(1) as a % of Quarterly Average
Adj. EBITDA (excl. LCM/LIFO)(1) Has Seasonality
(1) See Appendix to this presentation for GAAP to Non GAAP, including LCM/LIFO adjustments.
(40%)
(20%)
0%
20%
40%$0
$25
$50
$75
$100
2Q15 4Q15 2Q16 4Q16 2Q17 4Q17 2Q18 4Q18
Adj. EBITDA (excl. LCM/LIFO) % Change in LLS (Inverted)
111% 110%
96%
80%
0%
50%
100%
150%
200%
Q1 Q2 Q3 Q42015 2016 2017 2018 2019
$ in millions
Fuel Products
15
16
Fuel Products Portfolio
Capacity: 60,000 bpd
Specialty & Fuels facility
Lower utilization rates as primary Specialty
facility in system
Shreveport, Louisiana
Capacity: 25,000 bpd
Fuels refinery; only remaining pure-play
fuels facility in the portfolio
Runs up to 100% cost-advantaged WCS-
priced crudes
Great Falls, Montana
Capacity: 21,000 bpd
Historically Fuels focused, becoming more
integrated as Specialty segment grows
San Antonio, Texas
Cost-Advantaged Crude Opportunities
− Three facilities: One pure-play fuels refinery & two integrated facilities (specialty chemicals and fuels products)
− Seasonally strongest in Q2 & Q3 (summer driving season)
− Focused on capturing cost-advantaged crude opportunities
• Heavy Canadian: Processing ~25,000 bpd of WCS-priced crudes
• Permian: Processing ~21,000 bpd of Midland-WTI priced crudes
Calumet’s Evolution
17
18
Our Transformation
Refocused operations on what Calumet does best – creating premium, specialty products
− Rationalized asset portfolio, reducing exposure to commodity-oriented and capital intensive businesses
− Initiated corporate culture change focused on cost and capital discipline to drive cash flow
Strengthened leadership across the company, from Executive Management to Plant & Product-level leaders
− Integrated in personnel with pedigree and experience initiating operational and organizational change across the industry
Restructured specialty segment to focus on four product lines
− Appointed dedicated general managers to drive P&L ownership / accountability and cash flow
− Supported by realigned sales teams, business development and analytical support
Completed three-year self-help program, delivering ~$182 million EBITDA vs. original 3-year goal of $150-$200 million
Refocused business on product innovation to grow EBITDA
ERP implementation enabling data-driven insights expected to drive further upside in both organic revenue and margin
Reset Self-Help & Turnaround Transform & Grow
M&A
Growth
Projects
Operational Excellence
Roadmap for Growth
Delivered $13.5 million in Self-Help in 1Q19
− Focused effort on improving margins at Shreveport and San Antonio
refineries, delivering 2/3 of Self-Help to date
− Rationalized low margin sales in base oils, white oils, and finished
lubricants businesses
− Lower material and transportation costs, leveraging focused procurement
and supply chain activities
− Improved product netbacks with loading rack projects and local
placements
Expecting to capture $25-$40 million of Self-Help in FY’19
− New Versagel unit in Karns City started up in April
− Further benefits from expected rationalization, supply chain and business
unit optimization initiatives
19
Self-Help in Action: Delivering Results Across the Portfolio
Self-Help Phase I
Delivered ~$182 million EBITDA (2016-18)
vs. original 3-year goal of $150-$200 million
Self-Help Phase II
Goal of capturing an incremental
$100 million in EBITDA by YE 2021
Completed Projects in 2018
New Quick Hit-Projects
Supply Chain Initiatives
Cost Reductions
Raw Material Optimization
Margin Enhancements
20
Self-Help Phase II: Driving Specialty Products EBITDA
Project Cost to Achieve Time to AchievePotential
Contribution(1) Description
Completed
Improvement
Projects
Completed in
20182019 $20-30 million
New packaging lines at Porter and Shreveport facilities to improve
operating costs and expand capacity
PDA modifications at Shreveport refinery to improve high value
specialty yields
San Antonio refinery ISOM and Great Falls refinery naphtha project
to upgrade commodity intermediate streams
New Quick-Hit
Projects$15-25 million 2019-2021 $30-35 million
New Versagel project in Karns City facility capitalizing on R&D
initiatives
Four debottlenecking projects at Cotton Valley's solvent facility
decreasing feed costs and improving specialty yield
Princeton facility vacuum tower project upgrading asphalt to specialty
products
BT commercialization project at Missouri esters plant
Supply Chain
Initiatives$10-15 million 2019-2021 $30-35 million
Leverage new ERP platform to drive transportation savings and
reduce procurement spend
Streamline business by reducing non-core, high cost offerings
Improve logistics infrastructure and reduce capital intensive off-sites
(1) Projected EBITDA contribution following completion of the projects
Financial Update
21
22
Increasing Contribution from Specialty Products
$1,252 $1,300 $1,382 $1,413
$1,541
$2,463 $2,115 $2,186
2016 2017 2018 LTM 3/31/19
Specialty Fuel
Pro Forma Revenue by Segment(1)
$ in millions
(1) Pro forma for sale of Anchor & Superior Assets. `
Specialty Products expected to grow in 2019 and onwards, driven by realization of benefits from
ERP implementation and Self-Help initiatives
23
Self-Help Driving Continued Profitability Improvement
LTM Pro Forma Profitability
$52
$171
$238
$285
$99
$162
$215
$287
$0
$50
$100
$150
$200
$250
$300
1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19
LTM Pro Forma Adj EBITDA LTM Pro Forma Adj. EBITDA (excl. LCM/LIFO)(1) (1)
(1) See Appendix to this presentation for GAAP to Non-GAAP, including LCM/LIFO adjustments.
Pro Forma for Sale of Anchor & Superior Refinery$ in millions
24
Consistent Free Cash Flow Generation
$73
$98 $89
$30
$72 $65
$57
$107
$60
$44 $45 $47 $47 $45 $38 $38 $35 $32
$12 $21 $19
$28 $23
$12 $21
$20
$11
$18
$32 $23
$4
$16
$52
$16
1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19
Adj. EBITDA (excl. LCM/LIFO) Interest Capex
Free cash flow (excluding working capital) has been mostly positive through recent quarters
Capital structure actions (redemption of Secured Notes, etc.) have improved interest burden on cash flows
($2)
Heavy turnaround activity across both
businesses
$114 million of free cash flow generated since 2017
Note: Free Cash Flow defined as Adjusted EBITDA (excl. LCM/LIFO) less Interest Expense & Capex.
(1) See Appendix to this presentation for GAAP to Non GAAP, including LCM/LIFO adjustments.
(2) Includes capital improvement, replacement, environmental, and turnaround capital expenditures as reported. Excludes capital expenditures associated with JVs or acquisitions.
(2)
$ in millions
(1)
($46)
Overhang from ERP implementation
Divestments Impact
Net Debt to LTM Adj. EBITDA (Leverage) Ratio (As Reported)
25
Improving Credit Metrics
(1) Fixed Charge Coverage Ratio is defined as Adjusted EBITDA divided by consolidated interest expense (plus capitalized interest), neither of which has been pro-forma adjusted for acquisitions or refinancing activity .
(2) Excludes $350 million of restricted cash.
Significant improvement in credit metrics since 2016,
accelerated by divestment of non-core fuel assets (Superior,
Anchor & Dakota Prairie)
Strengthening profitability and focus on resilient Specialty
business has further driven down net leverage to current level
of 4.9x
Improvement in credit quality evidenced by upgrade to B3 by
Moody’s (July 2019) and B- by S&P (February 2018)
Liquidity Availability ($MM) Fixed Charge Coverage Ratio(1)
(2)(2)
26
2Q19 Outlook
Specialty Products
− Seasonally stronger quarter
− Continued weakness in base oil industry margins
− 10 day catalyst changeout at Shreveport paraffinic lubricants unit
− Further rationalization of low margin SKUs and products
Fuel Products
− Advantaged crude differentials starting to widen
− Status of RINs hardship applications
Corporate / Strategic
− Continue Self-Help Phase II initiatives
− Opportunistic bond repurchases
27
2021 Senior Notes Refinancing Strategy
Calumet has significantly reduced the minimum bond offering size through business performance and working cap optimization efforts
Given growth in excess liquidity (above $250MM minimum per internal policy), refinancing needs are currently ~$670MM
Currently exploring options to further optimize refinancing of 2021 notes
$850 $126
$57 $667
2021 Notes Cash Balance Excess Liquidity(above $250MM
minimum)
Min IssueProceeds
Other Initiatives Pro FormaMin IssueProceeds
(2)
(1) Pro forma for $26.8mm of 2021 Notes repurchased in April 2019.
(2) Excess liquidity as of 3/31/2019, calculated as $342.4 mm ABL borrowing base less $35.7mm outstanding standby letters of credit and no outstanding borrowings.
Potential to further reduce size of bond
issue through:
Use of cash flows to repurchase notes
Working capital improvements
Expansion of corporate revolver
Pro Forma 3/31/2019(1)
$ in millions
28
Summary and Key Takeaways
Strong execution against turnaround strategy, realigning portfolio towards higher-margin,
higher value Specialty Products
Commitment to continued balance sheet improvement
Cash flows poised to benefit from completed supply chain and raw material efficiencies, with
additional upside via “Self-Help Phase II” initiative
Leading integrated producer of high-quality, specialty hydrocarbon products
Strategic focus on product innovation and opportunistic growth projects to grow Specialty
Products EBITDA
Appendix
29
What We Do
Manufacture and sell finished lubricant, chemical and engineered fuel products to
consumer, commercial and industrial trade channels
Private label packaging
Automotive Landscape EquipmentMining
Specialty Lubricants
Performance Additives
Motor Oils/Filters
Transmission fluids
Gear Oil
Rust Preventives
Synthetic Lubricants
Bearing Greases
Gear Lubricants
Propel Lubricants
Hydraulic Oil
Precision-engineered
premixed fuel with synthetic
lubricants and advanced
stabilizers
Royal Purple is a premium, high
performance brand with proprietary
technology
Bel-Ray has a rich heritage in
performance greases, oils &
chemicals
TruFuel is a category innovator that
delivers superior performance and
convenience
Continue to be market leader in
engineered fuels and continue to
develop this key market
Focus efforts on SKU's in
growth markets
Focus on U.S. market and capture
further distribution and cost
advantages
Refocus on high value sales in
growth market segments
Simplify by shedding low margin
business (tolling, etc.)
Strategic InitiativesHow We Compete
Applications
Business StrategyOperational Footprint
30
Specialty Products – Finished Lubricants & Chemicals
What We Do
Provide superior customer service in meeting needs of customers
Develop custom blends and other products for customer’s unique needs
Products include:
− Penreco white oils, petrolatums and gels
− Waxes
− Esters
− Biosynthetic Technologies (BST)
Leverage unique new products for
customers (e.g. Versastique™)
Capitalize on our R&D and custom
blends to sell the value of product
Provide superior customer focus
and experience
Penreco brand recognition since
late 1800s
Leverage backwards integration
with other assets
Use system capacity to grow esters
business & develop
Biosynthetic market
Innovation & new products
(Versastique™)
Debottleneck Versagel
Improve supply chain in white
oils business
Strategic InitiativesHow We Compete
Customer Relationships
Business StrategyOperational Footprint
31
Specialty Products – Specialty Oils & Waxes
What We Do
Offer a wide range of solvents for the following markets:
− Aluminum rolling oils; Mining extraction; Oil Field applications; Water
Treatment; Consumer goods (auto aftermarket); Paints & Coatings
Primary products include specialty aliphatic solvents, and other branded solvents
such as Conosol®, Drakesol®, and Matgiesol®
Calumet solvents can be found in many household brands
Provide superior customer focus
and experience
Cotton Valley is only dedicated
solvents facility in US (others run
batch production inside larger
refineries)
Competitively advantaged as our
Cotton Valley facility uses crude oil
instead of diesel as a feedstock
Target high value-add markets
where there is less supply and
higher barriers to entry
Improve raw material flexibility for
advantaged crudes and feedstocks
Improve products with product
segregation projects
Strategic InitiativesHow We Compete
Customer Relationships
Business StrategyOperational Footprint
32
Specialty Products – Solvents
Aluminum Mining Oil & Gas
Water Treatment Consumer Paints & Coatings
What We Do
Offer extensive product line of both naphthenic base oils and paraffinic base oils
for the following markets:
− Passenger car engine oils; Heavy duty engine oils; Other automotive oils;
Marine oils; Rail oils; Industrial oils; Greases; Process oils; Shock
absorber oils
Refined in-house and are used in a wide variety of applications ranging from
aviation hydraulic fluids and heat transfer fluids to industrial lubricants
Calumet base oils can be found in many well-known brands:
Provide superior customer focus
and experience
Deliver product in size/container
and labeling that customer desires
High grade sales into markets that
value higher solvency and broad
viscosity ranges which tend to have
stickier customer relationships
Debottleneck paraffinic and
naphthenic capacity
Improve raw material flexibility for
advantaged crudes
Reduce costs through better
utilization and supply chain
efficiency
Strategic InitiativesHow We Compete
Key End Markets
Business StrategyOperational Footprint
33
Specialty Products – Base Oils
White oils upgrade
Conversion to
Greases
Motor Oils
Industrial Oils
Hydraulic Oils
Railroad Engine Oils
Shock Absorber Oils
Cutting Oils
34
Adjusted EBITDA(*) Bridge – 1Q19 vs. 1Q18 ($MM)
(1) Adjusted to remove $1.4 million from the divestiture of Anchor Drilling Fluids USA, LLC in 4Q17
(2) Includes plant operating and maintenance costs including RINs activities
(3) Includes transportation costs, hedging activities and 2017 RINs activities related to the Superior refinery in 1Q18
(*) See Appendix to this presentation for GAAP to Non-GAAP, including LCM/LIFO adjustments
35
Quarter-over-Quarter Cash Bridge ($MM)
(1) Includes proceeds from inventory financing obligations
36
Historical and Projected Capital Spending ($MM)
2019 Forecast
$80-$90
2019 CapEx forecast of $80-$90 million
1Q19
$276$304
$65
$20 $20
$49 $52
$34 $40
$55
2014 2015 2016 2017 2018
Growth Replacement Environmental Turnaround
37
Maintenance vs. Growth Capex Pro-Forma for Sale of Anchor & Superior Assets
Stay-in-business capital for Core Assets has historically averaged $34mm/yr
Stay in business capital for the Pro Forma company averages $46mm/yr
$37 $36 $39
$16 $10
$45 $41
$28 $27 $29
2014 2015 2016 2017 2018
$240$269
$27 $4 $9
$5 $11
$6 $13
$27
2014 2015 2016 2017 2018
Co
re A
sset
sN
on
-Co
re
Ass
ets
Tota
l Ass
ets
Note: Does not include capex associated with the divested assets (Anchor, Superior) and JVs. Numbers may not sum due to rounding.
$ in millions
38
Current Capitalization
(1) Pro forma for $26.8mm of 2021 Notes repurchased in April 2019.
Note: Adjusted EBITDA as reported.
($ in millions) 3/31/19 Principal Current Next Call
Current x Adj. EBITDA Issued Maturity Coupon Floor Ratings Call Price Date Price
Cash & Equivalents(1) $126
ABL Facility $0 $600 Feb-23 0.000% NR / NR / BB- - - -
Capital Lease Obligations 3
Secured Debt $3 0.0x
Senior Notes(1) $850 $900 Apr-21 6.500% - Caa1 / B- / B- 100.000 - -
Senior Notes 350 350 Jan-22 7.625% - Caa1 / B- / B- 101.906 Jan-20 100.000
Senior Notes 325 325 Apr-23 7.750% - Caa1 / B- / B- 103.875 Apr-20 101.938
Other Debt 5
Total Debt $1,533 5.4x
Market Capitalization $324
Total Capitalization $1,857 6.5x
Letters of Credit $36
Summary Financials LTM Credit Ratings Moody's S&P Fitch
Revenue $3,598 Corporate B3 B- B-
Adj. EBITDA 285 Senior Secured NR NR BB-
Interest Expense 136 Senior Unsecured Caa1 B- B-
Capital Expenditures 42 Outlook Stable Stable Stable
Last Action Jul-19 Feb-18 Apr-19
Credit Statistics LTM
Secured Debt / Adj. EBITDA 0.0x
Total Debt / Adj. EBITDA 5.4x
Net Debt / Adj. EBITDA 4.9x
Adj. EBITDA / Interest Expense 2.1x
Debt / Capitalization 83%
Liquidity Current
ABL Borrowing Base $342
Less: Revolver Borrowings -
Less: Revolver LC's (36)
Plus: Cash & Equivalents 126
Total Liquidity $433
39
EXHIBIT A: Reconciliation of Segment Adjusted EBITDA to Net
Income (Loss)
(1) In 2018, the Company and The Heritage Group formed Biosyn Holdings, LLC (“Biosyn”) for the purposes of acquiring Biosynthetic Technologies, LLC (“Biosynthetic Technologies”), a startup company which developed an intellectual property
portfolio for the manufacture of renewable-based and bioegradable esters. The initial cash investment of $3.8 million made by the Company into Biosyn was expensed in the period ended March 31, 2018 given Biosyn’s operations were all
related to research and development. The Company accounts for its ownership in Biosyn under the equity method of accounting. During March 2019, the Company sold its investment to The Heritage Group and recognized a gain of $5.0 million.
For comparability purposes, $3.8 million of the gain is included in Adjusted EBITDA for the period ended March 31, 2019
($ in millions) 3/31/17 6/30/17 9/30/17 12/31/17 3/31/18 06/30/18 09/30/18 12/31/18 03/31/19
Segment Adjusted EBITDA
Specialty products Adjusted EBITDA $ 45.6 $ 67.1 $ 43.0 $ 30.8 $ 37.7 $ 53.7 $ 37.0 $ 31.8 $ 56.3
Fuel products Adjusted EBITDA 36.8 34.0 46.3 10.7 38.7 25.6 17.5 21.9 41.4
Discontinued operations Adjusted EBITDA (3.7) 0.5 6.4 (0.3) (1.4) (0.4) (0.2) 2.0 —
Adjusted EBITDA $ 78.7 $ 101.6 $ 95.7 $ 41.2 $ 75.0 $ 78.9 $ 54.3 $ 55.7 $ 97.7
Less:
Unrealized (gain) loss on derivative Instruments
$ (10.6) $ (1.3) $ — $ (1.4) $ (2.0) $ (0.8) $ 2.4 $ (29.8) $ 2.6
Realized (gain) loss derivative activities, not included in net income (loss) or settled in a prior period
— — 9.7 — — 2.1 0.7 (2.8) —
Amortization of turnaround costs 7.4 6.6 6.4 3.9 3.3 2.7 2.7 4.1 4.8
(Gain) loss on debt extinguishment costs — — — — 0.6 58.2 — — (0.4)
(Gain) loss on the sale of businesses, net — — — (173.4) 1.6 (1.8) (3.4) 2.9 —
Impairment charges 0.4 — — 206.9 — — — — —
Gain on sale of unconsolidated affiliate — — — — — — — — (1.2)
Loss on impairment and disposal of assets 1.3 0.2 2.4 0.2 0.5 0.7 0.9 3.2 11.7
Equity based compensation and other items 1.5 2.0 4.9 3.4 1.1 1.9 (0.2) (4.1) 3.4
EBITDA $ 78.7 $ 94.1 $ 72.3 $ 1.6 $ 69.9 $ 15.9 $ 51.2 $ 82.2 $ 76.8
Less:
Interest expense $ 43.9 $ 44.5 $ 47.4 $ 47.3 $ 45.2 $ 37.5 $ 37.7 $ 35.1 $ 32.3
Depreciation and amortization 41.1 40.9 48.6 37.9 29.7 29.5 29.6 29.3 28.2
Income tax expense (benefit) (0.1) (0.9) (0.1) — (0.2) 0.8 0.4 (0.3) (0.1)
Net income (loss) $ (6.2) $ 9.6 $ (23.6) $ (83.6) $ (4.8) $ (51.9) $ (16.5) $ 18.1 $ 16.4
40
EXHIBIT B: Reconciliation of Net Income (Loss) to Adjusted
EBITDA and Pro Forma Adjusted EBITDA (ex-LCM/LIFO)
(1) Pro forma adjusts for divestitures of the Superior Refinery and Anchor Drilling Fluids USA, LLC in 4Q17
(2) In 2018, the Company and The Heritage Group formed Biosyn Holdings, LLC (“Biosyn”) for the purposes of acquiring Biosynthetic Technologies, LLC (“Biosynthetic Technologies”), a startup company which developed an intellectual property
portfolio for the manufacture of renewable-based and bioegradable esters. The initial cash investment of $3.8 million made by the Company into Biosyn was expensed in the period ended March 31, 2018 given Biosyn’s operations were all
related to research and development. The Company accounts for its ownership in Biosyn under the equity method of accounting. During March 2019, the Company sold its investment to The Heritage Group and recognized a gain of $5.0 million.
For comparability purposes, $3.8 million of the gain is included in Adjusted EBITDA for the period ended March 31, 2019
($ in millions) 3/31/17 6/30/17 9/30/17 12/31/17 3/31/18 06/30/18 09/30/18 12/31/18 03/31/19
Net income (loss) $ (6.2) $ 9.6 $ (23.6) $ (83.6) $ (4.8) $ (51.9) $ (16.5) $ 18.1 $ 16.4
Add:
Interest expense $ 43.9 $ 44.5 $ 47.4 $ 47.3 $ 45.2 $ 37.5 $ 37.7 $ 35.1 $ 32.3
Depreciation and amortization 41.1 40.9 48.6 37.9 29.7 29.5 29.6 29.3 28.2
Income tax expense (benefit) (0.1) (0.9) (0.1) — (0.2) 0.8 0.4 (0.3) (0.1)
EBITDA $ 78.7 $ 94.1 $ 72.3 $ 1.6 $ 69.9 $ 15.9 $ 51.2 $ 82.2 $ 76.8
Add:
Unrealized (gain) loss on derivative Instruments $ (10.6) $ (1.3) $ — $ (1.4) $ (2.0) $ (0.8) $ 2.4 $ (29.8) $ 2.6
Realized (gain) loss derivative activities, not included in net income (loss) or settled in a prior period
— — 9.7 — — 2.1 0.7 (2.8) —
Amortization of turnaround costs 7.4 6.6 6.4 3.9 3.3 2.7 2.7 4.1 4.8
(Gain) loss on debt extinguishment costs — — — — 0.6 58.2 — — (0.4)
(Gain) loss on the sale of businesses, net — — — (173.4) 1.6 (1.8) (3.4) 2.9 —
Impairment charges 0.4 — — 206.9 — — — — —
Gain on sale of unconsolidated affiliate — — — — — — — — (1.2)
Loss on impairment and disposal of assets 1.3 0.2 2.4 0.2 0.5 0.7 0.9 3.2 11.7
Equity based compensation and other items 1.5 2.0 4.9 3.4 1.1 1.9 (0.2) (4.1) 3.4
Adjusted EBITDA $ 78.7 $ 101.6 $ 95.7 $ 41.2 $ 75.0 $ 78.9 $ 54.3 $ 55.7 $ 97.7
Less:
Discontinued operations Adjusted EBITDA (3.7) 0.5 6.4 (0.3) (1.4) (0.4) (0.2) 2.0 —
Superior Adjusted EBITDA 21.3 27.9 25.6 16.8 — — — — —
Total pro forma Adjusted EBITDA(1) 61.1 73.2 63.7 24.7 76.4 79.3 54.5 53.7 97.7
LCM inventory adjustments (5.4) (3.8) (7.3) (14.1) (3.1) (14.0) 2.3 45.4 (38.9)
LIFO inventory layer adjustments — — 0.8 2.9 — — 0.4 5.9 0.9
Less: Superior LIFO/LCM 4.2 5.6 (5.0) 0.5 — — — — —
Pro forma EBITDA (excluding LCM/LIFO)(1) 59.9 75.0 52.2 14.0 73.3 65.3 57.2 105.0 59.7
Adjusted EBITDA (excluding LCM/LIFO) 73.3 97.8 89.2 30.0 71.9 64.9 57.0 107.0 59.7
(2)
41
EXHIBIT C: Reconciliation of Operating Metrics (ex-LCM/LIFO)
Three months ended March 31,
($ in millions, except per barrel data) 2019 2018
Specialty Adjusted EBITDA $56.3 $37.7
LCM inventory adjustments (6.6) (2.2)
LIFO inventory layer adjustments 0.9 —
Specialty Adjusted EBITDA (ex-LCM/LIFO) $50.6 $35.5
Fuels Adjusted EBITDA $41.4 $38.7
LCM inventory adjustments (32.3) (0.9)
LIFO inventory layer adjustments — —
Fuels Adjusted EBITDA (ex-LCM/LIFO) $9.1 $37.8
Continuing Operations Adjusted EBITDA $97.7 $76.4
Discontinued Operations Adjusted EBITDA — (1.4)
Total Adjusted EBITDA 97.7 75.0
LCM inventory adjustments (38.9) (3.1)
LIFO inventory layer adjustments 0.9 —
Total Adjusted EBITDA (ex-LCM/LIFO) $59.7 $71.9
Reported Specialty gross profit per barrel $38.07 $33.11
LCM/LIFO inventory adjustments per barrel (2.34) (1.05)
Specialty gross profit per barrel (ex-LCM/LIFO) $35.73 $32.06
Reported Fuels gross profit per barrel $5.85 $7.49
LCM/LIFO inventory adjustments per barrel (4.38) (0.15)
Fuels gross profit per barrel (ex-LCM/LIFO) $1.47 $7.34
42
EXHIBIT D: Reconciliation of Net Income (Loss) to Adjusted
Net Income (Loss)
Three months ended March 31,
($ in millions, except per barrel data) 2019 2018
Net income (loss) $ 16.4 $ (4.8)
LCM inventory adjustments (38.9) (3.1)
LIFO inventory layer adjustments 0.9 —
Unrealized (gain) loss on derivative instruments 2.6 (2.0)
(Gain) loss on debt extinguishment cost (0.4) 0.6
Amortization of turnaround costs 4.8 3.3
Gain on sale of unconsolidated affiliate (1.2) —
Loss on impairment and disposal of assets 11.7 0.5
Equity based compensation and other non-cash items 3.4 2.7
Adjusted net loss $ (0.7) $ (2.8)
Adjusted net loss per unit $ (0.01) $ (0.04)
Average limited partner units - diluted 78,175,007 78,045,360
43
Key Market Indices for Calumet
Specialty Products
Fuel Products
Base Oils
Specialty Solvents
Specialty White Oils, Petrolatums and Waxes
ICIS Group I 200 (Paraffinic)
ICIS Pale 500(Naphthenic)
Ultra Low Sulfur Diesel
ICIS Group II 600
Crack Spreads
Crude Differentials
Rack Differentials
2:1:1 Gulf Coast
WTI / WCS (Great Falls)
Great Falls vs. Gulf Coast
LLS / WTI (San Antonio)Midland WTI (Shreveport,
San Antonio)
San Antonio vs. Gulf Coast
Shreveport vs. Gulf Coast
ICIS Group I 600 (Paraffinic)